Defining Nonadherence and Nonpersistence to Anti–Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Defining Nonadherence and Nonpersistence to Anti–Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration

Published:2021-07-01 Issue:7 Volume:139 Page:769
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Okada Mali¹,Wong Tien Yin²³,Mitchell Paul⁴,Eldem Bora⁵,Talks S. James⁶,Aslam Tariq⁷,Daien Vincent⁸,Rodriguez Francisco J.⁹,Gale Richard¹⁰,Barratt Jane¹¹,Finger Robert P.¹²,Loewenstein Anat¹³

Affiliation:

1. Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia

2. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore

3. Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore

4. Westmead Institute for Medical Research, University of Sydney, Sydney, Australia

5. Department of Ophthalmology, Hacettepe University, Ankara, Turkey

6. The Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, United Kingdom

7. Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester School of Health Sciences, Manchester, United Kingdom

8. Montpellier University Hospital, Montpellier, France

9. Fundación Oftalmologica Nacional, Universidad del Rosario School of Medicine, Bogotá, Colombia

10. Department of Ophthalmology, York Teaching Hospital NHS Foundation Trust, York, United Kingdom

11. International Federation on Ageing, Toronto, Ontario, Canada

12. Department of Ophthalmology, University of Bonn, Bonn, Germany

13. Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2780579/jamaophthalmology_okada_2021_oi_210029_1632339313.50906.pdf

Reference41 articles.

1. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.;Solomon;Cochrane Database Syst Rev,2019

2. Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration.;Kim;Retina,2016

3. Association of visit adherence and visual acuity in patients with neovascular age-related macular degeneration: secondary analysis of the Comparison of Age-Related Macular Degeneration Treatment trial.;Ramakrishnan;JAMA Ophthalmol,2020

4. Medication compliance and persistence: terminology and definitions.;Cramer;Value Health,2008

5. Nonadherence or nonpersistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review.;Okada;Ophthalmology,2021

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C176-loaded and phosphatidylserine-modified nanoparticles treat retinal neovascularization by promoting M2 macrophage polarization;Bioactive Materials;2024-09

2. Exploring factors affected timely receiving intravitreal anti-VEGF treatment in patients with Diabetic Macular Edema: a qualitative interview study analyzed with COM-B model;2024-04-12

3. Understanding Loss to Follow-Up in AMD Patients Receiving VEGF Inhibitor Therapy: Associated Factors and Underlying Reasons;Diagnostics;2024-02-12

5. XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration;Ophthalmology and Therapy;2024-01-10